Reiko Inagi

12.9k total citations · 1 hit paper
194 papers, 10.1k citations indexed

About

Reiko Inagi is a scholar working on Nephrology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Reiko Inagi has authored 194 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Nephrology, 56 papers in Molecular Biology and 43 papers in Clinical Biochemistry. Recurrent topics in Reiko Inagi's work include Advanced Glycation End Products research (39 papers), Chronic Kidney Disease and Diabetes (31 papers) and Endoplasmic Reticulum Stress and Disease (21 papers). Reiko Inagi is often cited by papers focused on Advanced Glycation End Products research (39 papers), Chronic Kidney Disease and Diabetes (31 papers) and Endoplasmic Reticulum Stress and Disease (21 papers). Reiko Inagi collaborates with scholars based in Japan, United States and Belgium. Reiko Inagi's co-authors include Masaomi Nangaku, Toshio Miyata, Toshiro Fujita, Tetsuhiro Tanaka, Kiyoshi Kurokawa, Yu Ishimoto, Hiroshi Nishi, Hiroshi Maekawa, Charles van Ypersele de Strihou and Takamoto Ohse and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Reiko Inagi

192 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury

2019 419 citations Tsuyoshi Inoue, Tzu‐Ming Jao et al. profile →

Peers

Countries citing papers authored by Reiko Inagi

Since Specialization

Citations

This map shows the geographic impact of Reiko Inagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reiko Inagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reiko Inagi more than expected).

Fields of papers citing papers by Reiko Inagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reiko Inagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reiko Inagi. The network helps show where Reiko Inagi may publish in the future.

Co-authorship network of co-authors of Reiko Inagi

This figure shows the co-authorship network connecting the top 25 collaborators of Reiko Inagi. A scholar is included among the top collaborators of Reiko Inagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reiko Inagi. Reiko Inagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detection of Fast Decliner of Diabetic Kidney Disease Using Chiral Amino Acid Profiling: A Pilot Study 2025 ·Chemistry & Biodiversity ·Yosuke Hirakawa, Tomonori Kimura, (unknown), Masayuki Mizui, (unknown), (unknown), Masaomi Nangaku, Reiko Inagi	1
2	Organelle Communication: Joined in Sickness and in Health 2023 ·Physiology ·Roberto Bravo, Camila López‐Crisosto, Alfredo Criollo, Reiko Inagi, Sergio Lavandero	6
3	Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner 2023 ·Physiological Reports ·(unknown), Yosuke Hirakawa, Reiko Inagi, Masaomi Nangaku	13
4	Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease 2021 ·Kidney International ·Kentaro Yoshioka, Yosuke Hirakawa, Makoto Kurano, (unknown), Yoko Ono, (unknown), (unknown), Kuniyuki Kano, S. Hasegawa, Tsuyoshi Inoue, Takashi Shimada, Junken Aoki, Yutaka Yatomi, Masaomi Nangaku, Reiko Inagi	68
5	Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping review 2021 ·BMJ Open ·Ikechi G. Okpechi, Fergus Caskey, Abduzhappar Gaipov, Elliot Koranteng Tannor, (unknown), Gloria Ashuntantang, Jo‐Ann Donner, Ana Elizabeth Figueiredo, Reiko Inagi, Magdalena Madero, Charu Malik, (unknown), Roberto Pecoits‐Filho, Vladimı́r Tesař, Adeera Levin, Vivekanand Jha	5
6	Pathophysiology and therapeutics of premature ageing in chronic kidney disease, with a focus on glycative stress 2017 ·Clinical and Experimental Pharmacology and Physiology ·Yosuke Hirakawa, Tzu‐Ming Jao, Reiko Inagi	9
7	Endoplasmic reticulum stress signal impairs erythropoietin production: a role for ATF4 2012 ·American Journal of Physiology-Cell Physiology ·Chih‐Kang Chiang, Masaomi Nangaku, Tetsuhiro Tanaka, Takao Iwawaki, Reiko Inagi	38
8	Metallothionein is upregulated by hypoxia and stabilizes hypoxia-inducible factor in the kidney 2009 ·Kidney International ·Ichiro Kojima, Tetsuhiro Tanaka, Reiko Inagi, Hiroshi Nishi, Hiroyuki Aburatani, Hideki Kato, Toshio Miyata, Toshiro Fujita, Masaomi Nangaku	44
9	Protective Role of Hypoxia-Inducible Factor-2α against Ischemic Damage and Oxidative Stress in the Kidney 2007 ·Journal of the American Society of Nephrology ·Ichiro Kojima, Tetsuhiro Tanaka, Reiko Inagi, Hideki Kato, Toshiharu Yamashita, (unknown), Osamu Ohneda, Norihiko Takeda, Masataka Sata, Toshio Miyata, Toshiro Fujita, Masaomi Nangaku	111
10	Angiotensin-Induced Hypoxia in the Kidney: Functional and Structural Changes of the Renal Circulation 2007 ·Advances in experimental medicine and biology ·Masaomi Nangaku, Reiko Inagi, Toshio Miyata, Toshiro Fujita	9
11	Receptor-independent intracellular radical scavenging activity of an angiotensin II receptor blocker 2007 ·Journal of Hypertension ·Jing Shao, Masaomi Nangaku, Reiko Inagi, Hideki Kato, Toshio Miyata, Taiji Matsusaka, Eisei Noiri, Toshiro Fujita	32
12	Protection of Endothelial Cells by Dextran Sulfate in Rats with Thrombotic Microangiopathy 2005 ·Journal of the American Society of Nephrology ·Nobuaki Eto, Ichiro Kojima, Noriko Uesugi, Reiko Inagi, Toshio Miyata, Toshiro Fujita, Richard J. Johnson, Stuart J. Shankland, Masaomi Nangaku	12
13	Hypoxia in Renal Disease with Proteinuria and/or Glomerular Hypertension 2004 ·American Journal Of Pathology ·Tetsuhiro Tanaka, Toshio Miyata, Reiko Inagi, Toshiro Fujita, Masaomi Nangaku	86
14	Proteomics and Mesangial Cell: Serpin, Megsin and Plasmin 2003 ·Contributions to nephrology ·(unknown), Reiko Inagi, Toshio Miyata, Masaomi Nangaku, (unknown)	2
15	Human Herpesvirus 6B Infection of the Large Intestine of Patients with Diarrhea 2003 ·Clinical Infectious Diseases ·Kiyoko Amo, Keiko Tanaka‐Taya, Reiko Inagi, Hiromi Miyagawa, Hiroko Miyoshi, (unknown), Junji Sashihara, Junichi Hara, Masahiro Nakayama, Koichi Yamanishi, Shintaro Okada	24
16	Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion 2002 ·Journal of Clinical Investigation ·Toshio Miyata, Reiko Inagi, Masaomi Nangaku, Toshiyuki Imasawa, Masahiro Sato, Yuko Izuhara, Daisuke Suzuki, (unknown), Hiroshi Onogi, Minoru Kimura, Satoshi Sugiyama, Kiyoshi Kurokawa	36
17	Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion 2002 ·Journal of Clinical Investigation ·Toshio Miyata, Reiko Inagi, Masaomi Nangaku, Toshiyuki Imasawa, Masahiro Sato, Yuko Izuhara, Daisuke Suzuki, (unknown), Hiroshi Onogi, Minoru Kimura, Satoshi Sugiyama, Kiyoshi Kurokawa	3
18	Human Herpesvirus 6 Infection as a Risk Factor for the Development of Severe Drug-Induced Hypersensitivity Syndrome 1998 ·Archives of Dermatology ·Yosuke Suzuki, Reiko Inagi, Toshiya Aono, Koichi Yamanishi, Tetsuo Shiohara	255
19	Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids 1998 ·FEBS Letters ·Toshio Miyata, Reiko Inagi, Koichi Asahi, Yukihiro Yamada, Katsunori Horie, Hideto Sakai, Kôji Uchida, Kiyoshi Kurokawa	120
20	beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. 1993 ·Journal of Clinical Investigation ·Toshio Miyata, Osamu Oda, Reiko Inagi, Yuichiro Iida, Norie Araki, Norio Yamada, Seikoh Horiuchi, Naoyuki Taniguchi, Kenji Maeda, Taroh Kinoshita	348

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact